CoChat
Sign Up
Cited by 44

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Novel subcellular localization for α-synuclein: possible functional consequences

Guardia-Laguarta, Cristina, Area-Gomez, Estela, Schon, Eric A., Przedborski, Serge·2015·Frontiers in Neuroanatomy
DOI 10.3389/fnana.2015.00017PMC PMC4337379
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnana.2015.00017

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 95

  1. Area-Gomez, 2009, Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria, Am. J. Pathol., 175, 1810, 10.2353/ajpath.2009.090219 · DOI · Paper page
  2. Auluck, 2010, α-Synuclein: membrane interactions and toxicity in Parkinson’s disease, Annu. Rev. Cell Dev. Biol., 26, 211, 10.1146/annurev.cellbio.042308.113313 · DOI
  3. Baloh, 2007, Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations, J. Neurosci., 27, 422, 10.1523/jneurosci.4798-06.2007 · DOI
  4. Bar-On, 2008, Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson’s disease, J. Neurochem., 105, 1656, 10.1111/j.1471-4159.2008.05254.x · DOI
  5. Betarbet, 2000, Chronic systemic pesticide exposure reproduces features of Parkinson’s disease, Nat. Neurosci., 3, 1301, 10.1038/81834 · DOI
  6. Braak, 2003, Staging of brain pathology related to sporadic Parkinson’s disease, Neurobiol. Aging, 24, 197, 10.1016/s0197-4580(02)00065-9 · DOI · Paper page
  7. Bui, 2010, Rab32 modulates apoptosis onset and Mitochondria-Associated Membrane (MAM) properties, J. Biol. Chem., 285, 31590, 10.1074/jbc.M110.101584 · DOI
  8. Cabin, 2002, Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein, J. Neurosci., 22, 8797, 10.1523/JNEUROSCI.22-20-08797.2002 · DOI · Paper page
  9. Calì, 2012, α-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions, J. Biol. Chem., 287, 17914, 10.1074/jbc.M111.302794 · DOI
  10. Calì, 2013, Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics, Biochim. Biophys. Acta, 1832, 495, 10.1016/j.bbadis.2013.01.004 · DOI
  11. Chan, 2006, Mitochondrial fusion and fission in mammals, Annu. Rev. Cell Dev. Biol., 22, 79, 10.1146/annurev.cellbio.22.010305.104638 · DOI · Paper page
  12. Chen, 2009, Mitochondrial dynamics–fusion, fission, movement and mitophagy–in neurodegenerative diseases, Hum. Mol. Genet., 18, R169, 10.1093/hmg/ddp326 · DOI
  13. Chinta, 2010, Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo, Neurosci. Lett., 486, 235, 10.1016/j.neulet.2010.09.061 · DOI
  14. Choubey, 2011, Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy, J. Biol. Chem., 286, 10814, 10.1074/jbc.M110.132514 · DOI
  15. Chu, 2007, Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson’s disease?, Neurobiol. Dis., 25, 134, 10.1016/j.nbd.2006.08.021 · DOI
  16. Ciarlo, 2010, Association of fission proteins with mitochondrial raft-like domains, Cell Death Differ., 17, 1047, 10.1038/cdd.2009.208 · DOI
  17. Cole, 2008, Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification, Exp. Cell Res., 314, 2076, 10.1016/j.yexcr.2008.03.012 · DOI
  18. Cole, 2002, Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein alpha-synuclein, J. Biol. Chem., 277, 6344, 10.1074/jbc.m108414200 · DOI · Paper page
  19. Csordás, 2009, SR/ER-mitochondrial local communication: calcium and ROS, Biochim. Biophys. Acta, 1787, 1352, 10.1016/j.bbabio.2009.06.004 · DOI
  20. Csordás, 2006, Structural and functional features and significance of the physical linkage between ER and mitochondria, J. Cell Biol., 174, 915, 10.1083/jcb.200604016 · DOI
  21. Csordás, 2010, Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface, Mol. Cell, 39, 121, 10.1016/j.molcel.2010.06.029 · DOI · Paper page
  22. Dauer, 2003, Parkinson’s disease: mechanisms and models, Neuron, 39, 889, 10.1016/S0896-6273(03)00568-3 · DOI · Paper page
  23. Davidson, 1998, Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes, J. Biol. Chem., 273, 9443, 10.1074/jbc.273.16.9443 · DOI
  24. de Brito, 2008, Mitofusin 2 tethers endoplasmic reticulum to mitochondria, Nature, 456, 605, 10.1038/nature07534 · DOI · Paper page
  25. de Brito, 2010, An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship, EMBO J., 29, 2715, 10.1038/emboj.2010.177 · DOI
  26. De Franceschi, 2009, Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid, J. Mol. Biol., 394, 94, 10.1016/j.jmb.2009.09.008 · DOI
  27. de Lau, 2006, Serum cholesterol levels and the risk of Parkinson’s disease, Am. J. Epidemiol., 164, 998, 10.1093/aje/kwj283 · DOI
  28. Devi, 2008, Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain, J. Biol. Chem., 283, 9089, 10.1074/jbc.M710012200 · DOI
  29. Eliezer, 2001, Conformational properties of alpha-synuclein in its free and lipid-associated states, J. Mol. Biol., 307, 1061, 10.1006/jmbi.2001.4538 · DOI
  30. Elkon, 2002, Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase, J. Mol. Neurosci., 18, 229, 10.1385/jmn:18:3:229 · DOI
  31. Fabelo, 2011, Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson’s disease and incidental Parkinson’s disease, Mol. Med., 17, 1107, 10.2119/molmed.2011.00119 · DOI
  32. Fantini, 2013, The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside-and cholesterol-binding domains, Adv. Exp. Med. Biol., 991, 15, 10.1007/978-94-007-6331-9_2 · DOI
  33. Fortin, 2004, Lipid rafts mediate the synaptic localization of alpha-synuclein, J. Neurosci., 24, 6715, 10.1523/jneurosci.1594-04.2004 · DOI
  34. Friedman, 2011, ER tubules mark sites of mitochondrial division, Science, 334, 358, 10.1126/science.1207385 · DOI · Paper page
  35. Galvin, 1999, Axon pathology in Parkinson’s disease and Lewy body dementia hippocampus contains α-, β- and γ-synuclein, Proc. Natl. Acad. Sci. U S A, 96, 13450, 10.1073/pnas.96.23.13450 · DOI
  36. Garofalo, 2005, Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells, Cell Death Differ., 12, 1378, 10.1038/sj.cdd.4401672 · DOI
  37. Gitler, 2008, The Parkinson’s disease protein alpha-synuclein disrupts cellular Rab homeostasis, Proc. Natl. Acad. Sci. U S A, 105, 145, 10.1073/pnas.0710685105 · DOI
  38. Goldberg, 2000, Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease?, Nat. Cell Biol., 2, E115, 10.1038/35017124 · DOI
  39. Guardia-Laguarta, 2014, α-Synuclein is localized to mitochondria-associated ER membranes, J. Neurosci., 34, 249, 10.1523/JNEUROSCI.2507-13.2014 · DOI · Paper page
  40. Hamasaki, 2013, Autophagosomes form at ER-mitochondria contact sites, Nature, 495, 389, 10.1038/nature11910 · DOI · Paper page
  41. Hayashi, 2010, Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction, Mol. Pharmacol., 77, 517, 10.1124/mol.109.062539 · DOI
  42. Hayashi, 2009, MAM: more than just a housekeeper, Trends Cell Biol., 19, 81, 10.1016/j.tcb.2008.12.002 · DOI · Paper page
  43. Hodge, 1997, Regulation of metabolite flux through voltage-gating of VDAC channels, J. Membr. Biol., 157, 271, 10.1007/s002329900235 · DOI
  44. Hsu, 2000, α-synuclein promotes mitochondrial deficit and oxidative stress, Am. J. Pathol., 157, 401, 10.1016/s0002-9440(10)64553-1 · DOI
  45. Hu, 2008, Total cholesterol and the risk of Parkinson disease, Neurology, 70, 1972, 10.1212/01.wnl.0000312511.62699.a8 · DOI
  46. Huang, 2007, Lower low-density lipoprotein cholesterol levels are associated with Parkinson’s disease, Mov. Disord., 22, 377, 10.1002/mds.21290 · DOI
  47. Iwasawa, 2011, Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction, EMBO J., 30, 556, 10.1038/emboj.2010.346 · DOI · Paper page
  48. Jao, 2004, Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling, Proc. Natl. Acad. Sci. U S A, 101, 8331, 10.1073/pnas.0400553101 · DOI
  49. Jao, 2008, Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement, Proc. Natl. Acad. Sci. U S A, 105, 19666, 10.1073/pnas.0807826105 · DOI
  50. Jenner, 2003, Oxidative stress in Parkinson’s disease, Ann. Neurol., 53, S26, 10.1002/ana.10483 · DOI · Paper page
  51. Kahle, 2000, Subcellular localization of wild-type and Parkinson’s disease-associated mutant alpha -synuclein in human and transgenic mouse brain, J. Neurosci., 20, 6365, 10.1523/JNEUROSCI.20-17-06365.2000 · DOI
  52. Kamp, 2010, Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1, EMBO J., 29, 3571, 10.1038/emboj.2010.223 · DOI
  53. Kidd, 2000, Parkinson’s disease as multifactorial oxidative neurodegeneration: implications for integrative management, Altern. Med. Rev., 5, 502
  54. Kraytsberg, 2006, Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons, Nat. Genet., 38, 518, 10.1038/ng1778 · DOI
  55. Krüger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease, Nat. Genet., 18, 106, 10.1038/ng0298-106 · DOI · Paper page
  56. Langston, 1983, Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561 · DOI · Paper page
  57. Lee, 2002, Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form, J. Biol. Chem., 277, 671, 10.1074/jbc.m107045200 · DOI
  58. Lee, 2006, Impairment of microtubule-dependent trafficking by overexpression of α-synuclein, Eur. J. Neurosci., 24, 3153, 10.1111/j.1460-9568.2006.05210.x · DOI
  59. Levine, 2005, Endoplasmic reticulum: one continuous network compartmentalized by extrinsic cues, Curr. Opin. Cell Biol., 17, 362, 10.1016/j.ceb.2005.06.005 · DOI
  60. Li, 2007, Localization of alpha-synuclein to mitochondria within midbrain of mice, Neuroreport, 18, 1543, 10.1097/wnr.0b013e3282f03db4 · DOI
  61. Maroteaux, 1988, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci., 8, 2804, 10.1523/JNEUROSCI.08-08-02804.1988 · DOI
  62. Masliah, 1996, Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer’s disease, Am. J. Pathol., 148, 201
  63. Mavlyutov, 2012, Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase, Neuroscience, 206, 60, 10.1016/j.neuroscience.2011.12.040 · DOI
  64. McNulty, 1980, Ultrastructural obsevations on synaptic ribbons in the pineal organ of the goldfish, Cell Tissue Res., 210, 249, 10.1007/bf00237613 · DOI
  65. Murphy, 2000, Synucleins are developmentally expressed and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons, J. Neurosci., 20, 3214, 10.1523/JNEUROSCI.20-09-03214.2000 · DOI
  66. Nakamura, 2011, Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein α-synuclein, J. Biol. Chem., 286, 20710, 10.1074/jbc.M110.213538 · DOI
  67. Narhi, 1999, Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation, J. Biol. Chem., 274, 9843, 10.1074/jbc.274.14.9843 · DOI
  68. Ostrerova-Golts, 2000, The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity, J. Neurosci., 20, 6048, 10.1523/JNEUROSCI.20-16-06048.2000 · DOI
  69. Parihar, 2008, Mitochondrial association of alpha-synuclein causes oxidative stress, Cell. Mol. Life Sci., 65, 1272, 10.1007/s00018-008-7589-1 · DOI
  70. Parkinson, 2002, An essay on the shaking palsy. 1817, J. Neuropsychiatry Clin. Neurosci., 14, 223, 10.1176/appi.neuropsych.14.2.223 · DOI
  71. Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease, Science, 276, 2045, 10.1126/science.276.5321.2045 · DOI · Paper page
  72. Rizzuto, 2009, Ca(2+) transfer from the ER to mitochondria: when, how and why, Biochim. Biophys. Acta, 1787, 1342, 10.1016/j.bbabio.2009.03.015 · DOI
  73. Rizzuto, 1998, Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses, Science, 280, 1763, 10.1126/science.280.5370.1763 · DOI · Paper page
  74. Ross, 2001, Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson’s disease, Neuroscience, 102, 899, 10.1016/s0306-4522(00)00501-7 · DOI
  75. Rusiñol, 1994, A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins, J. Biol. Chem., 269, 27494, 10.1016/S0021-9258(18)47012-3 · DOI
  76. Sampaio-Marques, 2012, SNCA (α-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy, Autophagy, 8, 1494, 10.4161/auto.21275 · DOI
  77. Schon, 2011, Mitochondria: the next (neurode)generation, Neuron, 70, 1033, 10.1016/j.neuron.2011.06.003 · DOI · Paper page
  78. Shavali, 2008, Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells, Neurosci. Lett., 439, 125, 10.1016/j.neulet.2008.05.005 · DOI
  79. Simons, 2000, Lipid rafts and signal transduction, Nat. Rev. Mol. Cell Biol., 1, 31, 10.1038/35036052 · DOI · Paper page
  80. Singleton, 2003, α-Synuclein locus triplication causes Parkinson’s disease, Science, 302, 841, 10.1126/science.1090278 · DOI · Paper page
  81. Spillantini, 1998, α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies, Proc. Natl. Acad. Sci. U S A, 95, 6469, 10.1073/pnas.95.11.6469 · DOI · Paper page
  82. Spillantini, 1997, α-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 · DOI · Paper page
  83. Tabas, 2011, Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress, Nat. Cell Biol., 13, 184, 10.1038/ncb0311-184 · DOI
  84. Taxi, 1995, Effects of axotomy, deafferentation and reinnervation on sympathetic ganglionic synapses: a comparative study, Int. Rev. Cytol., 159, 195, 10.1016/s0074-7696(08)62108-7 · DOI
  85. Twig, 2011, The interplay between mitochondrial dynamics and mitophagy, Antioxid. Redox Signal., 14, 1939, 10.1089/ars.2010.3779 · DOI · Paper page
  86. Uéda, 1993, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. U S A, 90, 11282, 10.1073/pnas.90.23.11282 · DOI
  87. Vance, 1990, Phospholipid synthesis in a membrane fraction associated with mitochondria, J. Biol. Chem., 265, 7248, 10.1016/S0021-9258(19)39106-9 · DOI
  88. Wang, 2008, Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patients, Am. J. Pathol., 173, 470, 10.2353/ajpath.2008.071208 · DOI · Paper page
  89. Wang, 2009, The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease, J. Neurochem., 109, 153, 10.1111/j.1471-4159.2009.05867.x · DOI
  90. Watanabe, 1976, Junctional subsurface organs in frog sympathetic ganglion cells, J. Neurocytol., 5, 125, 10.1007/bf01176186 · DOI
  91. Weihofen, 2009, Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking, Biochemistry, 48, 2045, 10.1021/bi8019178 · DOI
  92. Yu, 2011, The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons, Hum. Mol. Genet., 20, 3227, 10.1093/hmg/ddr235 · DOI
  93. Zarranz, 2004, The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol., 55, 164, 10.1002/ana.10795 · DOI · Paper page
  94. Zhang, 2008, Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody, Brain Res., 1244, 40, 10.1016/j.brainres.2008.08.067 · DOI
  95. Zigoneanu, 2012, Interaction of α-synuclein with vesicles that mimic mitochondrial membranes, Biochim. Biophys. Acta, 1818, 512, 10.1016/j.bbamem.2011.11.024 · DOI

Cited by

Sorted by citations

Metadata

Authors
Guardia-Laguarta, C., Area-Gomez, E., Schon, E. A., & Przedborski, S.
Venue
Frontiers in Neuroanatomy
Publisher
Frontiers Media SA
Published
2015-02-23
Volume
9
ISSN
1662-5129
DOI
10.3389/fnana.2015.00017
PMC
PMC4337379
Cited by
44
References
9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review